PDB Short entry for 1DXQ HEADER FLAVOPROTEIN 14-JAN-00 1DXQ TITLE CRYSTAL STRUCTURE OF MOUSE NAD[P]H-QUINONE OXIDOREDUCTASE COMPND MOL_ID: 1; COMPND 2 MOLECULE: QUINONE REDUCTASE; COMPND 3 CHAIN: A, B, C, D; COMPND 4 SYNONYM: DT-DIAPHORASE, NAD(P)H DEHYDROGENASE [QUINONE] 1, DTD, COMPND 5 AZOREDUCTASE, PHYLLOQUINONE REDUCTASE, MENADIONE REDUCTASE; COMPND 6 EC: 1.6.99.2; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: MUS MUSCULUS; SOURCE 3 ORGANISM_COMMON: MOUSE; SOURCE 4 ORGANISM_TAXID: 10090; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS FLAVOPROTEIN, DT-DIAPHORASE, CANCER, CHEMOPROTECTION, CHEMOTHERAPY, KEYWDS 2 DEHYDROGENASEROSSMAN FOLD, OXIDOREDUCTASE EXPDTA X-RAY DIFFRACTION AUTHOR M.FAIG,M.A.BIANCHET,S.CHEN,S.WINSKI,D.ROSS,L.M.AMZEL REVDAT 4 06-DEC-23 1DXQ 1 REMARK REVDAT 3 05-JUL-17 1DXQ 1 REMARK REVDAT 2 24-FEB-09 1DXQ 1 VERSN REVDAT 1 17-APR-00 1DXQ 0 JRNL AUTH M.FAIG,M.A.BIANCHET,S.CHEN,S.WINSKI,D.ROSS,P.TALALAY, JRNL AUTH 2 L.M.AMZEL JRNL TITL STRUCTURES OF RECOMBINANT MOUSE AND HUMAN NAD(P)H:QUINONE JRNL TITL 2 OXIDOREDUCTASES:SPECIES COMPARISON AND STRUCTURAL CHANGES JRNL TITL 3 WITH SUBSTRATE BINDING AND RELEASE JRNL REF PROC.NATL.ACAD.SCI.USA V. 97 3177 2000 JRNL REFN ISSN 0027-8424 JRNL PMID 10706635 JRNL DOI 10.1073/PNAS.050585797 REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH M.A.BIANCHET,C.FOSTER,M.FAIG,P.TALALAY,L.M.AMZEL REMARK 1 TITL STRUCTURE AND MECHANISM OF CYTOSOLIC QUINONE REDUCTASE REMARK 1 REF BIOCHEM.SOC.TRANS. V. 27 610 1999 REMARK 1 REFN ISSN 0300-5127 REMARK 1 PMID 10917652 REMARK 1 REFERENCE 2 REMARK 1 AUTH C.FOSTER,M.A.BIANCHET,P.TALALAY,Q.ZHAO,L.M.AMZEL REMARK 1 TITL CRYSTAL STRUCTURE OF HUMAN QUINONE REDUCTASE TYPE 2, A REMARK 1 TITL 2 METALLOPROTEIN REMARK 1 REF BIOCHEMISTRY V. 38 9881 1999 REMARK 1 REFN ISSN 0006-2960 REMARK 1 PMID 10433694 REMARK 1 DOI 10.1021/BI990799V REMARK 1 REFERENCE 3 REMARK 1 AUTH R.LI,M.A.BIANCHET,P.TALALAY,L.M.AMZEL REMARK 1 TITL THE THREE-DIMENSIONAL STRUCTURE OF NAD(P)H:QUINONE REMARK 1 TITL 2 REDUCTASE, A FLAVOPROTEIN INVOLVED IN CANCER CHEMOPROTECTION REMARK 1 TITL 3 AND CHEMOTHERAPY: MECHANISM OF TWO-ELECTRON REDUCTION REMARK 1 REF PROC.NATL.ACAD.SCI.USA V. 92 8846 1995 REMARK 1 REFN ISSN 0027-8424 REMARK 1 PMID 7568029 REMARK 1 DOI 10.1073/PNAS.92.19.8846 REMARK 2 REMARK 2 RESOLUTION. 2.80 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS 0.9 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.80 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 42.98 REMARK 3 DATA CUTOFF (SIGMA(F)) : 2.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : 1633136.180 REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 66.5 REMARK 3 NUMBER OF REFLECTIONS : 18847 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : NULL REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.207 REMARK 3 FREE R VALUE : 0.277 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.900 REMARK 3 FREE R VALUE TEST SET COUNT : 916 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.009 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 6 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.70 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.87 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 18.20 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 911 REMARK 3 BIN R VALUE (WORKING SET) : 0.3080 REMARK 3 BIN FREE R VALUE : 0.3570 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 4.40 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 42 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.055 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 8712 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 212 REMARK 3 SOLVENT ATOMS : 0 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 15.10 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 29.20 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 5.17000 REMARK 3 B22 (A**2) : -2.48000 REMARK 3 B33 (A**2) : -2.69000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 6.84000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.34 REMARK 3 ESD FROM SIGMAA (A) : 0.47 REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.46 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.60 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.010 REMARK 3 BOND ANGLES (DEGREES) : 1.400 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 21.80 REMARK 3 IMPROPER ANGLES (DEGREES) : 0.840 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : 1.330 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE (A**2) : 2.220 ; 2.000 REMARK 3 SIDE-CHAIN BOND (A**2) : 1.840 ; 2.000 REMARK 3 SIDE-CHAIN ANGLE (A**2) : 2.750 ; 2.500 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : FLAT MODEL REMARK 3 KSOL : 0.29 REMARK 3 BSOL : 25.00 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN_REP.PARAM REMARK 3 PARAMETER FILE 2 : FAD_XPLOR.PAR REMARK 3 PARAMETER FILE 3 : NULL REMARK 3 TOPOLOGY FILE 1 : PROTEIN.TOP REMARK 3 TOPOLOGY FILE 2 : FAD_XPLOR.TOP REMARK 3 TOPOLOGY FILE 3 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 1DXQ COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 14-JAN-00. REMARK 100 THE DEPOSITION ID IS D_1290004547. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : NULL REMARK 200 TEMPERATURE (KELVIN) : 100.0 REMARK 200 PH : 8.50 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU RUH2R REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : MIRRORS REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : R-AXIS IV REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 18847 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.800 REMARK 200 RESOLUTION RANGE LOW (A) : 42.980 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 66.5 REMARK 200 DATA REDUNDANCY : 2.500 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : 0.10000 REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : NULL REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : NULL REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: AMORE REMARK 200 STARTING MODEL: PDB ENTRY 1QRD REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 48.19 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.37 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PH 8.50 REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 85.81000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 300 REMARK: BIOLOGICAL_UNIT: DIMERIC REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PQS REMARK 350 TOTAL BURIED SURFACE AREA: 7410 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 26680 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -62.4 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PQS REMARK 350 TOTAL BURIED SURFACE AREA: 7160 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 26480 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -50.4 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: B, D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ARG A 3 -112.62 -159.78 REMARK 500 ARG A 52 17.65 -67.69 REMARK 500 LEU A 59 21.80 -76.44 REMARK 500 LYS A 60 -89.58 56.65 REMARK 500 LYS A 63 -69.59 -98.66 REMARK 500 ASN A 64 59.04 -97.07 REMARK 500 PHE A 106 15.63 58.56 REMARK 500 PHE A 124 -60.88 -106.45 REMARK 500 TYR A 132 -127.95 39.02 REMARK 500 ASP A 133 5.69 -60.03 REMARK 500 PHE A 181 155.04 -47.89 REMARK 500 SER A 191 87.43 34.12 REMARK 500 ASP A 198 -75.26 -55.84 REMARK 500 THR A 213 32.87 -141.76 REMARK 500 LEU A 230 76.08 -68.28 REMARK 500 LEU A 253 -61.73 -92.22 REMARK 500 HIS A 257 57.37 -108.59 REMARK 500 PRO A 264 -92.67 -25.38 REMARK 500 ALA A 265 -125.82 -167.32 REMARK 500 ARG A 272 -169.78 172.34 REMARK 500 ARG B 3 -112.55 -157.52 REMARK 500 ARG B 52 17.09 -68.12 REMARK 500 LEU B 59 20.94 -75.11 REMARK 500 LYS B 60 -89.06 56.81 REMARK 500 LYS B 63 -70.89 -98.31 REMARK 500 ASN B 64 59.92 -97.50 REMARK 500 PHE B 106 18.66 57.18 REMARK 500 TYR B 132 -127.68 39.81 REMARK 500 ASP B 133 6.56 -59.52 REMARK 500 GLN B 138 -18.11 -49.94 REMARK 500 ASP B 163 121.80 -38.72 REMARK 500 PHE B 181 155.51 -47.52 REMARK 500 SER B 191 88.69 33.14 REMARK 500 ASP B 198 -74.88 -55.33 REMARK 500 THR B 213 27.74 -140.34 REMARK 500 LEU B 230 75.84 -69.74 REMARK 500 GLN B 246 -19.90 -48.57 REMARK 500 LEU B 253 -62.60 -90.96 REMARK 500 HIS B 257 57.98 -109.24 REMARK 500 PRO B 264 -93.21 -25.26 REMARK 500 ALA B 265 -125.32 -165.82 REMARK 500 ARG B 272 -169.77 173.25 REMARK 500 ARG C 3 -111.59 -158.34 REMARK 500 ARG C 52 17.92 -68.25 REMARK 500 LEU C 59 22.50 -76.02 REMARK 500 LYS C 60 -89.98 56.66 REMARK 500 LYS C 63 -71.24 -98.51 REMARK 500 PHE C 106 18.61 55.81 REMARK 500 TYR C 132 -128.67 38.09 REMARK 500 ASP C 133 7.04 -59.05 REMARK 500 REMARK 500 THIS ENTRY HAS 83 RAMACHANDRAN OUTLIERS. REMARK 500 REMARK 500 REMARK: NULL REMARK 700 REMARK 700 SHEET REMARK 700 DETERMINATION METHOD: DSSP REMARK 700 THERE ARE SEVERAL BIFURCATED SHEETS IN THIS STRUCTURE. REMARK 700 EACH IS REPRESENTED BY TWO SHEETS WHICH HAVE ONE OR MORE REMARK 700 IDENTICAL STRANDS. REMARK 700 SHEETS A AND A1 REPRESENT ONE BIFURCATED SHEET IN CHAIN A REMARK 700 SHEETS B AND B1 REPRESENT ONE BIFURCATED SHEET IN CHAIN D REMARK 700 SHEETS C AND C1 REPRESENT ONE BIFURCATED SHEET IN CHAIN C REMARK 700 SHEETS D AND D1 REPRESENT ONE BIFURCATED SHEET IN CHAIN D REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE FAD A 300 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE FAD B 300 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE FAD C 300 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE FAD D 300 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1DXO RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN NAD[P]H-QUINONE OXIDOREDUCTASE CO WITH 2, REMARK 900 3,5,6,TETRAMETHYL-P-BENZOQUINONE (DUROQUINONE) AT 2.5 ANGSTROM REMARK 900 RESOLUTION REMARK 900 RELATED ID: 1QRD RELATED DB: PDB REMARK 900 QUINONE REDUCTASE/FAD/CIBACRON BLUE/DUROQUINONE COMPLEX FROM RATTUS REMARK 900 RATTUS REMARK 900 RELATED ID: 1D4A RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN NAD[P]H-QUINONE OXIDOREDUCTASE AT 1.7 A REMARK 900 RESOLUTION DBREF 1DXQ A 1 273 UNP Q64669 DHQU_MOUSE 1 273 DBREF 1DXQ B 1 273 UNP Q64669 DHQU_MOUSE 1 273 DBREF 1DXQ C 1 273 UNP Q64669 DHQU_MOUSE 1 273 DBREF 1DXQ D 1 273 UNP Q64669 DHQU_MOUSE 1 273 SEQADV 1DXQ LEU A 238 UNP Q64669 MET 238 CONFLICT SEQADV 1DXQ MET A 239 UNP Q64669 LYS 239 CONFLICT SEQADV 1DXQ LEU B 238 UNP Q64669 MET 238 CONFLICT SEQADV 1DXQ MET B 239 UNP Q64669 LYS 239 CONFLICT SEQADV 1DXQ LEU C 238 UNP Q64669 MET 238 CONFLICT SEQADV 1DXQ MET C 239 UNP Q64669 LYS 239 CONFLICT SEQADV 1DXQ LEU D 238 UNP Q64669 MET 238 CONFLICT SEQADV 1DXQ MET D 239 UNP Q64669 LYS 239 CONFLICT SEQRES 1 A 273 ALA ALA ARG ARG ALA LEU ILE VAL LEU ALA HIS SER GLU SEQRES 2 A 273 LYS THR SER PHE ASN TYR ALA MET LYS GLU ALA ALA VAL SEQRES 3 A 273 GLU ALA LEU LYS LYS ARG GLY TRP GLU VAL LEU GLU SER SEQRES 4 A 273 ASP LEU TYR ALA MET ASN PHE ASN PRO ILE ILE SER ARG SEQRES 5 A 273 ASN ASP ILE THR GLY GLU LEU LYS ASP SER LYS ASN PHE SEQRES 6 A 273 GLN TYR PRO SER GLU SER SER LEU ALA TYR LYS GLU GLY SEQRES 7 A 273 ARG LEU SER PRO ASP ILE VAL ALA GLU HIS LYS LYS LEU SEQRES 8 A 273 GLU ALA ALA ASP LEU VAL ILE PHE GLN PHE PRO LEU GLN SEQRES 9 A 273 TRP PHE GLY VAL PRO ALA ILE LEU LYS GLY TRP PHE GLU SEQRES 10 A 273 ARG VAL LEU VAL ALA GLY PHE ALA TYR THR TYR ALA ALA SEQRES 11 A 273 MET TYR ASP ASN GLY PRO PHE GLN ASN LYS LYS THR LEU SEQRES 12 A 273 LEU SER ILE THR THR GLY GLY SER GLY SER MET TYR SER SEQRES 13 A 273 LEU GLN GLY VAL HIS GLY ASP MET ASN VAL ILE LEU TRP SEQRES 14 A 273 PRO ILE GLN SER GLY ILE LEU ARG PHE CYS GLY PHE GLN SEQRES 15 A 273 VAL LEU GLU PRO GLN LEU VAL TYR SER ILE GLY HIS THR SEQRES 16 A 273 PRO PRO ASP ALA ARG MET GLN ILE LEU GLU GLY TRP LYS SEQRES 17 A 273 LYS ARG LEU GLU THR VAL TRP GLU GLU THR PRO LEU TYR SEQRES 18 A 273 PHE ALA PRO SER SER LEU PHE ASP LEU ASN PHE GLN ALA SEQRES 19 A 273 GLY PHE LEU LEU MET LYS GLU VAL GLN GLU GLU GLN LYS SEQRES 20 A 273 LYS ASN LYS PHE GLY LEU SER VAL GLY HIS HIS LEU GLY SEQRES 21 A 273 LYS SER ILE PRO ALA ASP ASN GLN ILE LYS ALA ARG LYS SEQRES 1 B 273 ALA ALA ARG ARG ALA LEU ILE VAL LEU ALA HIS SER GLU SEQRES 2 B 273 LYS THR SER PHE ASN TYR ALA MET LYS GLU ALA ALA VAL SEQRES 3 B 273 GLU ALA LEU LYS LYS ARG GLY TRP GLU VAL LEU GLU SER SEQRES 4 B 273 ASP LEU TYR ALA MET ASN PHE ASN PRO ILE ILE SER ARG SEQRES 5 B 273 ASN ASP ILE THR GLY GLU LEU LYS ASP SER LYS ASN PHE SEQRES 6 B 273 GLN TYR PRO SER GLU SER SER LEU ALA TYR LYS GLU GLY SEQRES 7 B 273 ARG LEU SER PRO ASP ILE VAL ALA GLU HIS LYS LYS LEU SEQRES 8 B 273 GLU ALA ALA ASP LEU VAL ILE PHE GLN PHE PRO LEU GLN SEQRES 9 B 273 TRP PHE GLY VAL PRO ALA ILE LEU LYS GLY TRP PHE GLU SEQRES 10 B 273 ARG VAL LEU VAL ALA GLY PHE ALA TYR THR TYR ALA ALA SEQRES 11 B 273 MET TYR ASP ASN GLY PRO PHE GLN ASN LYS LYS THR LEU SEQRES 12 B 273 LEU SER ILE THR THR GLY GLY SER GLY SER MET TYR SER SEQRES 13 B 273 LEU GLN GLY VAL HIS GLY ASP MET ASN VAL ILE LEU TRP SEQRES 14 B 273 PRO ILE GLN SER GLY ILE LEU ARG PHE CYS GLY PHE GLN SEQRES 15 B 273 VAL LEU GLU PRO GLN LEU VAL TYR SER ILE GLY HIS THR SEQRES 16 B 273 PRO PRO ASP ALA ARG MET GLN ILE LEU GLU GLY TRP LYS SEQRES 17 B 273 LYS ARG LEU GLU THR VAL TRP GLU GLU THR PRO LEU TYR SEQRES 18 B 273 PHE ALA PRO SER SER LEU PHE ASP LEU ASN PHE GLN ALA SEQRES 19 B 273 GLY PHE LEU LEU MET LYS GLU VAL GLN GLU GLU GLN LYS SEQRES 20 B 273 LYS ASN LYS PHE GLY LEU SER VAL GLY HIS HIS LEU GLY SEQRES 21 B 273 LYS SER ILE PRO ALA ASP ASN GLN ILE LYS ALA ARG LYS SEQRES 1 C 273 ALA ALA ARG ARG ALA LEU ILE VAL LEU ALA HIS SER GLU SEQRES 2 C 273 LYS THR SER PHE ASN TYR ALA MET LYS GLU ALA ALA VAL SEQRES 3 C 273 GLU ALA LEU LYS LYS ARG GLY TRP GLU VAL LEU GLU SER SEQRES 4 C 273 ASP LEU TYR ALA MET ASN PHE ASN PRO ILE ILE SER ARG SEQRES 5 C 273 ASN ASP ILE THR GLY GLU LEU LYS ASP SER LYS ASN PHE SEQRES 6 C 273 GLN TYR PRO SER GLU SER SER LEU ALA TYR LYS GLU GLY SEQRES 7 C 273 ARG LEU SER PRO ASP ILE VAL ALA GLU HIS LYS LYS LEU SEQRES 8 C 273 GLU ALA ALA ASP LEU VAL ILE PHE GLN PHE PRO LEU GLN SEQRES 9 C 273 TRP PHE GLY VAL PRO ALA ILE LEU LYS GLY TRP PHE GLU SEQRES 10 C 273 ARG VAL LEU VAL ALA GLY PHE ALA TYR THR TYR ALA ALA SEQRES 11 C 273 MET TYR ASP ASN GLY PRO PHE GLN ASN LYS LYS THR LEU SEQRES 12 C 273 LEU SER ILE THR THR GLY GLY SER GLY SER MET TYR SER SEQRES 13 C 273 LEU GLN GLY VAL HIS GLY ASP MET ASN VAL ILE LEU TRP SEQRES 14 C 273 PRO ILE GLN SER GLY ILE LEU ARG PHE CYS GLY PHE GLN SEQRES 15 C 273 VAL LEU GLU PRO GLN LEU VAL TYR SER ILE GLY HIS THR SEQRES 16 C 273 PRO PRO ASP ALA ARG MET GLN ILE LEU GLU GLY TRP LYS SEQRES 17 C 273 LYS ARG LEU GLU THR VAL TRP GLU GLU THR PRO LEU TYR SEQRES 18 C 273 PHE ALA PRO SER SER LEU PHE ASP LEU ASN PHE GLN ALA SEQRES 19 C 273 GLY PHE LEU LEU MET LYS GLU VAL GLN GLU GLU GLN LYS SEQRES 20 C 273 LYS ASN LYS PHE GLY LEU SER VAL GLY HIS HIS LEU GLY SEQRES 21 C 273 LYS SER ILE PRO ALA ASP ASN GLN ILE LYS ALA ARG LYS SEQRES 1 D 273 ALA ALA ARG ARG ALA LEU ILE VAL LEU ALA HIS SER GLU SEQRES 2 D 273 LYS THR SER PHE ASN TYR ALA MET LYS GLU ALA ALA VAL SEQRES 3 D 273 GLU ALA LEU LYS LYS ARG GLY TRP GLU VAL LEU GLU SER SEQRES 4 D 273 ASP LEU TYR ALA MET ASN PHE ASN PRO ILE ILE SER ARG SEQRES 5 D 273 ASN ASP ILE THR GLY GLU LEU LYS ASP SER LYS ASN PHE SEQRES 6 D 273 GLN TYR PRO SER GLU SER SER LEU ALA TYR LYS GLU GLY SEQRES 7 D 273 ARG LEU SER PRO ASP ILE VAL ALA GLU HIS LYS LYS LEU SEQRES 8 D 273 GLU ALA ALA ASP LEU VAL ILE PHE GLN PHE PRO LEU GLN SEQRES 9 D 273 TRP PHE GLY VAL PRO ALA ILE LEU LYS GLY TRP PHE GLU SEQRES 10 D 273 ARG VAL LEU VAL ALA GLY PHE ALA TYR THR TYR ALA ALA SEQRES 11 D 273 MET TYR ASP ASN GLY PRO PHE GLN ASN LYS LYS THR LEU SEQRES 12 D 273 LEU SER ILE THR THR GLY GLY SER GLY SER MET TYR SER SEQRES 13 D 273 LEU GLN GLY VAL HIS GLY ASP MET ASN VAL ILE LEU TRP SEQRES 14 D 273 PRO ILE GLN SER GLY ILE LEU ARG PHE CYS GLY PHE GLN SEQRES 15 D 273 VAL LEU GLU PRO GLN LEU VAL TYR SER ILE GLY HIS THR SEQRES 16 D 273 PRO PRO ASP ALA ARG MET GLN ILE LEU GLU GLY TRP LYS SEQRES 17 D 273 LYS ARG LEU GLU THR VAL TRP GLU GLU THR PRO LEU TYR SEQRES 18 D 273 PHE ALA PRO SER SER LEU PHE ASP LEU ASN PHE GLN ALA SEQRES 19 D 273 GLY PHE LEU LEU MET LYS GLU VAL GLN GLU GLU GLN LYS SEQRES 20 D 273 LYS ASN LYS PHE GLY LEU SER VAL GLY HIS HIS LEU GLY SEQRES 21 D 273 LYS SER ILE PRO ALA ASP ASN GLN ILE LYS ALA ARG LYS HET FAD A 300 53 HET FAD B 300 53 HET FAD C 300 53 HET FAD D 300 53 HETNAM FAD FLAVIN-ADENINE DINUCLEOTIDE FORMUL 5 FAD 4(C27 H33 N9 O15 P2) HELIX 1 1 SER A 16 ARG A 32 1 17 HELIX 2 2 LEU A 41 ASN A 45 1 5 HELIX 3 3 GLN A 66 GLU A 77 1 12 HELIX 4 4 SER A 81 ALA A 94 1 14 HELIX 5 5 PRO A 109 LEU A 120 1 12 HELIX 6 6 MET A 131 GLY A 135 5 5 HELIX 7 7 SER A 151 SER A 156 5 6 HELIX 8 8 ASP A 163 SER A 173 1 11 HELIX 9 9 ILE A 175 GLY A 180 1 6 HELIX 10 10 PRO A 196 GLU A 212 1 17 HELIX 11 11 THR A 213 GLU A 217 5 5 HELIX 12 12 PRO A 224 LEU A 227 5 4 HELIX 13 13 MET A 239 LYS A 247 1 9 HELIX 14 14 SER B 16 ARG B 32 1 17 HELIX 15 15 LEU B 41 ASN B 45 1 5 HELIX 16 16 GLN B 66 GLU B 77 1 12 HELIX 17 17 SER B 81 ALA B 94 1 14 HELIX 18 18 PRO B 109 LEU B 120 1 12 HELIX 19 19 MET B 131 GLY B 135 5 5 HELIX 20 20 SER B 151 SER B 156 5 6 HELIX 21 21 ASP B 163 SER B 173 1 11 HELIX 22 22 ILE B 175 GLY B 180 1 6 HELIX 23 23 PRO B 196 GLU B 212 1 17 HELIX 24 24 THR B 213 GLU B 217 5 5 HELIX 25 25 PRO B 224 LEU B 227 5 4 HELIX 26 26 MET B 239 LYS B 247 1 9 HELIX 27 27 SER C 16 ARG C 32 1 17 HELIX 28 28 LEU C 41 ASN C 45 1 5 HELIX 29 29 GLN C 66 GLU C 77 1 12 HELIX 30 30 SER C 81 ALA C 94 1 14 HELIX 31 31 PRO C 109 LEU C 120 1 12 HELIX 32 32 MET C 131 GLY C 135 5 5 HELIX 33 33 SER C 151 SER C 156 5 6 HELIX 34 34 ASP C 163 SER C 173 1 11 HELIX 35 35 ILE C 175 GLY C 180 1 6 HELIX 36 36 PRO C 196 GLU C 212 1 17 HELIX 37 37 THR C 213 GLU C 217 5 5 HELIX 38 38 PRO C 224 LEU C 227 5 4 HELIX 39 39 MET C 239 LYS C 247 1 9 HELIX 40 40 SER D 16 ARG D 32 1 17 HELIX 41 41 LEU D 41 ASN D 45 1 5 HELIX 42 42 GLN D 66 GLU D 77 1 12 HELIX 43 43 SER D 81 ALA D 94 1 14 HELIX 44 44 PRO D 109 LEU D 120 1 12 HELIX 45 45 MET D 131 GLY D 135 5 5 HELIX 46 46 SER D 151 SER D 156 5 6 HELIX 47 47 ASP D 163 SER D 173 1 11 HELIX 48 48 ILE D 175 GLY D 180 1 6 HELIX 49 49 PRO D 196 GLU D 212 1 17 HELIX 50 50 THR D 213 GLU D 217 5 5 HELIX 51 51 PRO D 224 LEU D 227 5 4 HELIX 52 52 MET D 239 LYS D 247 1 9 SHEET 1 A 5 GLU A 35 ASP A 40 0 SHEET 2 A 5 ARG A 4 LEU A 9 1 O ALA A 5 N LEU A 37 SHEET 3 A 5 LEU A 96 PRO A 102 1 O LEU A 96 N LEU A 6 SHEET 4 A 5 LYS A 141 THR A 148 1 O LYS A 141 N VAL A 97 SHEET 5 A 5 GLN A 182 VAL A 183 1 O GLN A 182 N THR A 142 SHEET 1 A1 5 GLU A 35 ASP A 40 0 SHEET 2 A1 5 ARG A 4 LEU A 9 1 O ALA A 5 N LEU A 37 SHEET 3 A1 5 LEU A 96 PRO A 102 1 O LEU A 96 N LEU A 6 SHEET 4 A1 5 LYS A 141 THR A 148 1 O LYS A 141 N VAL A 97 SHEET 5 A1 5 GLN A 187 TYR A 190 1 O GLN A 187 N ILE A 146 SHEET 1 B 5 GLU B 35 ASP B 40 0 SHEET 2 B 5 ARG B 4 LEU B 9 1 O ALA B 5 N LEU B 37 SHEET 3 B 5 LEU B 96 PRO B 102 1 O LEU B 96 N LEU B 6 SHEET 4 B 5 LYS B 141 THR B 148 1 O LYS B 141 N VAL B 97 SHEET 5 B 5 GLN B 182 VAL B 183 1 O GLN B 182 N THR B 142 SHEET 1 B1 5 GLU B 35 ASP B 40 0 SHEET 2 B1 5 ARG B 4 LEU B 9 1 O ALA B 5 N LEU B 37 SHEET 3 B1 5 LEU B 96 PRO B 102 1 O LEU B 96 N LEU B 6 SHEET 4 B1 5 LYS B 141 THR B 148 1 O LYS B 141 N VAL B 97 SHEET 5 B1 5 GLN B 187 TYR B 190 1 O GLN B 187 N ILE B 146 SHEET 1 C 5 GLU C 35 ASP C 40 0 SHEET 2 C 5 ARG C 4 LEU C 9 1 O ALA C 5 N LEU C 37 SHEET 3 C 5 LEU C 96 PRO C 102 1 O LEU C 96 N LEU C 6 SHEET 4 C 5 LYS C 141 THR C 148 1 O LYS C 141 N VAL C 97 SHEET 5 C 5 GLN C 182 VAL C 183 1 O GLN C 182 N THR C 142 SHEET 1 C1 5 GLU C 35 ASP C 40 0 SHEET 2 C1 5 ARG C 4 LEU C 9 1 O ALA C 5 N LEU C 37 SHEET 3 C1 5 LEU C 96 PRO C 102 1 O LEU C 96 N LEU C 6 SHEET 4 C1 5 LYS C 141 THR C 148 1 O LYS C 141 N VAL C 97 SHEET 5 C1 5 GLN C 187 TYR C 190 1 O GLN C 187 N ILE C 146 SHEET 1 D 5 GLU D 35 ASP D 40 0 SHEET 2 D 5 ARG D 4 LEU D 9 1 O ALA D 5 N LEU D 37 SHEET 3 D 5 LEU D 96 PRO D 102 1 O LEU D 96 N LEU D 6 SHEET 4 D 5 LYS D 141 THR D 148 1 O LYS D 141 N VAL D 97 SHEET 5 D 5 GLN D 182 VAL D 183 1 O GLN D 182 N THR D 142 SHEET 1 D1 5 GLU D 35 ASP D 40 0 SHEET 2 D1 5 ARG D 4 LEU D 9 1 O ALA D 5 N LEU D 37 SHEET 3 D1 5 LEU D 96 PRO D 102 1 O LEU D 96 N LEU D 6 SHEET 4 D1 5 LYS D 141 THR D 148 1 O LYS D 141 N VAL D 97 SHEET 5 D1 5 GLN D 187 TYR D 190 1 O GLN D 187 N ILE D 146 SITE 1 AC1 21 HIS A 11 THR A 15 SER A 16 PHE A 17 SITE 2 AC1 21 ASN A 18 ALA A 20 PRO A 102 LEU A 103 SITE 3 AC1 21 GLN A 104 TRP A 105 PHE A 106 THR A 147 SITE 4 AC1 21 THR A 148 GLY A 149 GLY A 150 TYR A 155 SITE 5 AC1 21 ARG A 200 MET A 201 GLN C 66 PRO C 68 SITE 6 AC1 21 GLU C 117 SITE 1 AC2 22 LYS A 240 HIS B 11 THR B 15 SER B 16 SITE 2 AC2 22 PHE B 17 ASN B 18 ALA B 20 PRO B 102 SITE 3 AC2 22 LEU B 103 GLN B 104 TRP B 105 PHE B 106 SITE 4 AC2 22 THR B 147 THR B 148 GLY B 149 GLY B 150 SITE 5 AC2 22 TYR B 155 ARG B 200 MET B 201 GLN D 66 SITE 6 AC2 22 PRO D 68 GLU D 117 SITE 1 AC3 23 ASN A 64 GLN A 66 TYR A 67 PRO A 68 SITE 2 AC3 23 GLU A 117 HIS C 11 THR C 15 SER C 16 SITE 3 AC3 23 PHE C 17 ASN C 18 ALA C 20 PRO C 102 SITE 4 AC3 23 LEU C 103 GLN C 104 TRP C 105 PHE C 106 SITE 5 AC3 23 THR C 147 THR C 148 GLY C 149 GLY C 150 SITE 6 AC3 23 TYR C 155 ARG C 200 MET C 201 SITE 1 AC4 20 GLN B 66 PRO B 68 GLU B 117 HIS D 11 SITE 2 AC4 20 THR D 15 SER D 16 PHE D 17 ASN D 18 SITE 3 AC4 20 ALA D 20 PRO D 102 LEU D 103 GLN D 104 SITE 4 AC4 20 TRP D 105 PHE D 106 THR D 147 THR D 148 SITE 5 AC4 20 GLY D 149 GLY D 150 TYR D 155 ARG D 200 CRYST1 54.960 171.620 67.140 90.00 112.30 90.00 P 1 21 1 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.018195 0.000000 0.007462 0.00000 SCALE2 0.000000 0.005827 0.000000 0.00000 SCALE3 0.000000 0.000000 0.016098 0.00000